US5597809A
(en)
*
|
1994-06-23 |
1997-01-28 |
Massachusetts Eye & Ear Infirmary |
Treatment of optic neuritis
|
US5710165A
(en)
*
|
1994-07-06 |
1998-01-20 |
Synthelabo |
Use of polyamine antagonists for the treatment of glaucoma
|
AU716577B2
(en)
*
|
1994-07-06 |
2000-03-02 |
Sanofi-Aventis |
Use of polyamine antagonists for the treatment of glaucoma
|
JPH08231400A
(ja)
*
|
1995-02-24 |
1996-09-10 |
Rohto Pharmaceut Co Ltd |
イフェンプロジルを必須成分とする眼圧降下剤
|
JPH0967270A
(ja)
*
|
1995-08-31 |
1997-03-11 |
Res Dev Corp Of Japan |
水晶体混濁の予防および治療法、並びにそのための薬 剤
|
EP0861079A1
(de)
*
|
1995-11-17 |
1998-09-02 |
Alcon Laboratories, Inc. |
Kombinationstherapie zur behandlung von glaukom
|
US6441047B2
(en)
*
|
1995-11-17 |
2002-08-27 |
Alcon Manufacturing Ltd.. |
Combination therapy for treating glaucoma
|
US5780450A
(en)
*
|
1995-11-21 |
1998-07-14 |
Alcon Laboratories, Inc. |
Use of adenosine uptake inhibitors for treating retinal or optic nerve head damage
|
US5965534A
(en)
*
|
1995-11-22 |
1999-10-12 |
Alcon Laboratories, Inc. |
Use of ω-conotoxin analogs for treating retinal and optic nerve head damage
|
ES2238702T3
(es)
|
1995-12-21 |
2005-09-01 |
Alcon Laboratories, Inc. |
Utilizacion de ciertos compuestos de isoquinolinsulfonilo en el tratamiento de glaucomas y de isquemias oculares.
|
ZA9610738B
(en)
|
1995-12-22 |
1997-06-24 |
Warner Lambert Co |
Subtype selective nmda receptor ligands and the use thereof
|
ZA9610745B
(en)
*
|
1995-12-22 |
1997-06-24 |
Warner Lambert Co |
4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
|
ZA9610736B
(en)
|
1995-12-22 |
1997-06-27 |
Warner Lambert Co |
2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
|
ZA9610741B
(en)
|
1995-12-22 |
1997-06-24 |
Warner Lambert Co |
4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
|
ES2171233T3
(es)
*
|
1996-01-02 |
2002-09-01 |
Sanofi Synthelabo |
Uso de eliprodil para la preparacion de un medicamento para el tratamiento de trastornos isquemicos de la retina o el nervio optico.
|
WO1997033582A1
(fr)
*
|
1996-03-14 |
1997-09-18 |
Synthelabo |
Compositions d'antagonistes de site polyamine
|
US5891871A
(en)
*
|
1996-03-21 |
1999-04-06 |
Cocensys, Inc. |
Substituted 2,3-benzodiazepin-4-ones and the use thereof
|
EP0911027A4
(de)
*
|
1996-04-26 |
2000-11-29 |
Fujisawa Pharmaceutical Co |
Mittel die dihydropyridine enthalten zur verbesserung der durchblutung der augenumgebenden gewebe
|
US5891885A
(en)
*
|
1996-10-09 |
1999-04-06 |
Algos Pharmaceutical Corporation |
Method for treating migraine
|
CA2270119A1
(en)
*
|
1996-10-28 |
1998-05-07 |
Senju Pharmaceutical Co., Ltd. |
Drugs for ameliorating ocular circulatory disorders
|
AU731447B2
(en)
*
|
1996-12-16 |
2001-03-29 |
Alcon Laboratories, Inc. |
The topical use of kappa opioid agonists to treat ocular pain
|
WO1999000129A1
(en)
*
|
1997-06-30 |
1999-01-07 |
Dreyer Evan B |
Calcium blockers to treat proliferative vitreoretinopathy
|
US6159958A
(en)
*
|
1997-08-14 |
2000-12-12 |
The United States Of America As Represented By The Secretary Of The Army |
Treatment or prophylaxis of retinal pathology and spinal cord injury
|
AU1388999A
(en)
*
|
1997-12-16 |
1999-07-05 |
Alcon Laboratories, Inc. |
The use of nitric oxide generations for the treatment of dry eye disorders
|
WO1999042104A1
(en)
*
|
1998-02-23 |
1999-08-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Use of macrolide compounds for treating glaucoma
|
WO1999044612A1
(en)
|
1998-03-02 |
1999-09-10 |
Cocensys, Inc. |
Substituted quinazolines and analogs and the use thereof
|
AU5251999A
(en)
|
1998-08-04 |
2000-02-28 |
Wisconsin Alumni Research Foundation |
Method of reducing retinal ganglion cell degeneration
|
MXPA01006449A
(es)
*
|
1998-12-24 |
2002-04-24 |
R Tech Ueno Ltd |
Un agente para tratar el transtorno de la funcion de las celulas visuales.
|
US6864232B1
(en)
|
1998-12-24 |
2005-03-08 |
Sucampo Ag |
Agent for treating visual cell function disorder
|
WO2001010442A1
(fr)
*
|
1999-08-09 |
2001-02-15 |
Fujisawa Pharmaceutical Co., Ltd. |
Inhibiteurs de la mort de cellules ganglionnaires de la retine
|
US6174878B1
(en)
|
1999-08-31 |
2001-01-16 |
Alcon Laboratories, Inc. |
Topical use of kappa opioid agonists to treat otic pain
|
DK1227859T3
(da)
*
|
1999-11-12 |
2006-12-11 |
Alcon Inc |
Neurophilinligander til behandling af okulære tilstande
|
US6462066B2
(en)
|
1999-12-02 |
2002-10-08 |
University Of South Florida |
Method and composition for treatment of ischemic neuronal reperfusion injury
|
EP1252895A4
(de)
*
|
2000-01-31 |
2003-04-16 |
Santen Pharmaceutical Co Ltd |
Heilmittel für ophthalmologische zustände
|
US6444702B1
(en)
|
2000-02-22 |
2002-09-03 |
Neuromolecular, Inc. |
Aminoadamantane derivatives as therapeutic agents
|
CA2401775A1
(en)
*
|
2000-02-29 |
2001-09-07 |
Abbot F. Clark |
Diagnostics and therapeutics for glaucoma
|
AU2001219185A1
(en)
|
2000-03-17 |
2001-10-03 |
Alcon, Inc. |
2-acylaminobenzimidazole derivatives for treating glaucoma
|
US7012090B1
(en)
|
2000-03-17 |
2006-03-14 |
Alcon, Inc. |
Pyranoindoles for treating glaucoma
|
US6956036B1
(en)
|
2000-03-17 |
2005-10-18 |
Alcon, Inc. |
6-hydroxy-indazole derivatives for treating glaucoma
|
US6927233B1
(en)
|
2000-03-17 |
2005-08-09 |
Alcon, Inc. |
5ht2 agonists for controlling IOP and treating glaucoma
|
US6806285B1
(en)
|
2000-03-17 |
2004-10-19 |
Alcon, Inc. |
5-Hydroxyl indole derivatives for treating glaucoma
|
US7005443B1
(en)
|
2000-03-17 |
2006-02-28 |
Alcon, Inc. |
5-Hydroxy indazole derivatives for treating glaucoma
|
CN1680324A
(zh)
*
|
2000-05-30 |
2005-10-12 |
奥索-麦克尼尔药品公司 |
二氢吡啶软药及相关组合物和方法
|
PT2153819E
(pt)
|
2000-07-14 |
2012-11-14 |
Allergan Inc |
Utilização de um componente para aumento de solubilidade numa composição aquosa compreendendo tartarato de brimonidina
|
CA2429480A1
(en)
*
|
2000-11-22 |
2002-05-30 |
Tomiya Mano |
Ophthalmological preparations
|
FR2822706A1
(fr)
*
|
2001-03-29 |
2002-10-04 |
Univ Pasteur |
Utilisation de composes organiques antagonistes de recepteurs pour le traitement de la degenerescence retinienne
|
US6583152B2
(en)
|
2001-04-30 |
2003-06-24 |
Dexgen Pharmaceuticals, Inc. |
Composition for reducing the risk or progression of cardiovascular diseases
|
BR0210241A
(pt)
|
2001-06-01 |
2004-08-10 |
Alcon Inc |
Piranoindazóis e seu uso no tratamento de glaucoma
|
BR0210238A
(pt)
|
2001-06-01 |
2004-07-20 |
Alcon Inc |
Novos análogos de aril-amino-propano e seu uso para o tratamento de glaucoma
|
EP1392658A4
(de)
|
2001-06-01 |
2004-10-13 |
Alcon Inc |
Neue kondensierte indazole und indole und deren verwendung zur behandlung von glaucom
|
AU2003233729B2
(en)
|
2002-06-06 |
2007-10-04 |
Merck Frosst Canada Ltd |
1,5-distributed pyrrolid-2-one derivatives for use as EP4 receptor agonists in the treatment of eye diseases such as glaucoma
|
US8557855B2
(en)
*
|
2002-07-03 |
2013-10-15 |
Allergan, Inc. |
Methods of using ryanodine antagonists in treating neural injury
|
US7086532B2
(en)
*
|
2003-07-16 |
2006-08-08 |
Allergan, Inc. |
Titration/compliance pack with increasing doses
|
US7196082B2
(en)
|
2002-11-08 |
2007-03-27 |
Merck & Co. Inc. |
Ophthalmic compositions for treating ocular hypertension
|
WO2004043354A2
(en)
|
2002-11-08 |
2004-05-27 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
US7053085B2
(en)
|
2003-03-26 |
2006-05-30 |
Merck & Co. Inc. |
EP4 receptor agonist, compositions and methods thereof
|
AU2003300915B2
(en)
|
2002-12-13 |
2008-08-28 |
Alcon, Inc. |
Novel benzopyran analogs and their use for the treatment of glaucoma
|
WO2004058238A1
(en)
*
|
2002-12-23 |
2004-07-15 |
Alcon, Inc. |
Use of cathepsin k inhibitors for the treatment of glaucoma
|
WO2004069275A1
(ja)
*
|
2003-02-04 |
2004-08-19 |
Mitsubishi Pharma Corporation |
眼科用剤
|
US20050147584A1
(en)
*
|
2004-01-05 |
2005-07-07 |
Allergan, Inc. |
Compositions and methods comprising memantine and polyanionic polymers
|
US20050031652A1
(en)
*
|
2003-02-25 |
2005-02-10 |
Allergan, Inc. |
Compositions and methods comprising memantine and polyanionic polymers
|
US20040191332A1
(en)
*
|
2003-03-27 |
2004-09-30 |
Allergan, Inc. |
Preserved ophthalmic compositions
|
SI1614419T1
(sl)
|
2003-04-17 |
2012-12-31 |
Toyama Chemical Co., Ltd. |
Preventivno sredstvo/zdravilo za bolezni vidnega ĺ˝ivca, vsebujoäśe derivate alkil etra ali soli le-teh
|
AU2004263149B2
(en)
|
2003-08-07 |
2010-08-19 |
Allergan, Inc. |
Compositions for delivery of therapeutics into the eyes and methods for making and using same
|
CA2537119A1
(en)
|
2003-09-02 |
2005-03-10 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
CN1842335A
(zh)
|
2003-09-04 |
2006-10-04 |
默克公司 |
用于治疗高眼压的眼用组合物
|
ATE425971T1
(de)
|
2003-09-04 |
2009-04-15 |
Merck & Co Inc |
Ophthalmische zusammensetzungen zur behandlung der okularen hypertonie
|
US20070224278A1
(en)
*
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
US20050101582A1
(en)
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
US7476687B2
(en)
|
2003-11-26 |
2009-01-13 |
Alcon, Inc. |
Substituted furo[2,3-g]indazoles for the treatment of glaucoma
|
US6989445B2
(en)
|
2003-12-15 |
2006-01-24 |
Alcon, Inc. |
Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
|
US7338972B1
(en)
|
2003-12-15 |
2008-03-04 |
Alcon, Inc. |
Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
|
US7129257B1
(en)
|
2003-12-15 |
2006-10-31 |
Alcon, Inc. |
Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
|
US20050277698A1
(en)
*
|
2004-01-05 |
2005-12-15 |
Hughes Patrick M |
Memantine delivery to the back of the eye
|
AU2005209201B2
(en)
|
2004-01-20 |
2010-06-03 |
Allergan, Inc. |
Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
US20050244471A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
|
US20050244465A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
US8425929B2
(en)
*
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
BRPI0510485A
(pt)
|
2004-04-30 |
2007-11-13 |
Allergan Inc |
implantes inibidores de tirosina cinase intravìtreos biodegradáveis
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
US20050244461A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Controlled release drug delivery systems and methods for treatment of an eye
|
US7993634B2
(en)
*
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
US8119154B2
(en)
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
US8147865B2
(en)
*
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20050244463A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
US8455656B2
(en)
|
2004-04-30 |
2013-06-04 |
Allergan, Inc. |
Kinase inhibitors
|
US8673341B2
(en)
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
US20050244462A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Devices and methods for treating a mammalian eye
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
EP1773350B1
(de)
*
|
2004-07-12 |
2013-05-29 |
Allergan, Inc. |
Ophthalmische zusammensetzungen zur behandlung von augenleiden
|
CN1988903A
(zh)
|
2004-07-20 |
2007-06-27 |
默克公司 |
用于治疗高眼压症的眼用组合物
|
JP2008507557A
(ja)
*
|
2004-07-22 |
2008-03-13 |
ヴァンダ ファーマシューティカルズ インコーポレイテッド |
眼疾患の治療法
|
BRPI0513862A
(pt)
*
|
2004-07-26 |
2008-05-20 |
Allergan Inc |
métodos de tratar condições oftálmicas
|
WO2006043965A1
(en)
*
|
2004-10-14 |
2006-04-27 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
WO2006062839A1
(en)
|
2004-12-08 |
2006-06-15 |
Alcon, Inc. |
Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
|
EP1885689A1
(de)
*
|
2005-05-06 |
2008-02-13 |
Chevron U.S.A., Inc. |
Diamondoidderivate mit therapeutischer wirkung
|
US20080009546A1
(en)
*
|
2005-05-06 |
2008-01-10 |
Chevron U.S.A. Inc. |
Diamondoid derivatives possessing therapeutic activity in the treatment of neurologic disorders
|
CA2608476A1
(en)
*
|
2005-06-28 |
2007-01-04 |
Bausch & Lomb Incorporated |
Preparations comprising arylazine substituted with a carbonylic moiety to increase the activity of gelatinase a in ocular cells
|
US20070167527A1
(en)
*
|
2006-01-13 |
2007-07-19 |
Burke James A |
Memantine for the normalization of visual acuity deficits
|
US20090197930A1
(en)
*
|
2006-02-02 |
2009-08-06 |
Kenji Yoshida |
Eyedrops
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
US8969415B2
(en)
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
UY30883A1
(es)
|
2007-01-31 |
2008-05-31 |
Alcon Res |
Tapones punctales y metodos de liberacion de agentes terapeuticos
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
TW200845978A
(en)
*
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
US7911053B2
(en)
*
|
2007-04-19 |
2011-03-22 |
Marvell World Trade Ltd. |
Semiconductor packaging with internal wiring bus
|
NZ584152A
(en)
|
2007-09-14 |
2011-11-25 |
Ortho Mcneil Janssen Pharm |
1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
|
KR20100080597A
(ko)
*
|
2007-09-14 |
2010-07-09 |
오르토-맥닐-얀센 파마슈티칼스 인코포레이티드 |
1,3-이치환된-4-페닐-1h-피리딘-2-온
|
KR101520086B1
(ko)
*
|
2007-09-14 |
2015-05-14 |
얀센 파마슈티칼스 인코포레이티드 |
1´,3´-이치환된-4-페닐-3,4,5,6-테트라히드로-2h,1´h-[1,4´]비피리디닐-2´-온
|
JP5433582B2
(ja)
*
|
2007-11-14 |
2014-03-05 |
ジャンセン ファーマシューティカルズ, インコーポレイテッド. |
イミダゾ[1,2−a]ピリジン誘導体およびmGluR2受容体の正のアロステリック調節因子としてのその使用
|
US9192571B2
(en)
*
|
2008-03-03 |
2015-11-24 |
Allergan, Inc. |
Ketorolac tromethamine compositions for treating or preventing ocular pain
|
US7842714B2
(en)
*
|
2008-03-03 |
2010-11-30 |
Allergan, Inc. |
Ketorolac tromethamine compositions for treating ocular pain
|
CA2735764C
(en)
|
2008-09-02 |
2016-06-14 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
|
US8697689B2
(en)
|
2008-10-16 |
2014-04-15 |
Janssen Pharmaceuticals, Inc. |
Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
|
US8691813B2
(en)
|
2008-11-28 |
2014-04-08 |
Janssen Pharmaceuticals, Inc. |
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
|
CA2755118A1
(en)
*
|
2009-03-10 |
2010-09-16 |
Santen Pharmaceutical Co., Ltd. |
Preventive or therapeutic agents for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivatives or salts thereof as active ingredients
|
WO2010112615A1
(en)
|
2009-04-03 |
2010-10-07 |
Dsm Ip Assets B.V. |
Lysine derivatives functionalised with lipids
|
EA020671B1
(ru)
|
2009-05-12 |
2014-12-30 |
Янссен Фармасьютикалз, Инк. |
ПРОИЗВОДНЫЕ 1,2,4-ТРИАЗОЛО[4,3-a]ПИРИДИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ПОЛОЖИТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ mGluR2
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
BRPI1012870B8
(pt)
|
2009-05-12 |
2021-05-25 |
Addex Pharmaceuticals Sa |
derivados de 1,2,4-triazolo[4,3-a]piridina e seu uso como moduladores alostericos positivos de receptores de mglur2 e composição farmacêutica
|
WO2011009020A2
(en)
|
2009-07-16 |
2011-01-20 |
Mallinckrodt Inc. |
Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
|
CA2772877A1
(en)
*
|
2009-09-01 |
2011-03-10 |
Lz Therapeutics, Inc. |
Treatment of glaucoma and other retinopathies with gangliosides
|
BR112012004689A2
(pt)
|
2009-09-01 |
2019-09-24 |
Lz Therapeutics Inc |
métodos para extração e purificação de gangliosídeos.
|
US20110124736A1
(en)
|
2009-11-09 |
2011-05-26 |
Allergan, Inc. |
Compositions and methods for stimulating hair growth
|
WO2011127151A2
(en)
|
2010-04-07 |
2011-10-13 |
Allergan, Inc. |
Combinations of preservatives for ophthalmic compositions
|
CN102883709A
(zh)
|
2010-04-07 |
2013-01-16 |
阿勒根公司 |
用于眼用制剂的防腐组合物联合
|
JP5562716B2
(ja)
*
|
2010-05-12 |
2014-07-30 |
花王株式会社 |
電位依存性カチオンチャネル抑制剤
|
AU2011328203B2
(en)
|
2010-11-08 |
2015-03-19 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
PT2649069E
(pt)
|
2010-11-08 |
2015-11-20 |
Janssen Pharmaceuticals Inc |
Derivados de 1,2,4-triazolo[4,3-a]piridina e sua utilização como moduladores alostéricos positivos de recetores mglur2
|
US9012448B2
(en)
|
2010-11-08 |
2015-04-21 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
|
EP2602654B1
(de)
*
|
2011-12-08 |
2023-04-19 |
Essilor International |
Ophthalmischer Filter
|
CA2862157C
(en)
|
2012-01-20 |
2016-03-22 |
Garnet Biotherapeutics, Inc. |
Methods of ganglioside production
|
WO2014127243A1
(en)
|
2013-02-15 |
2014-08-21 |
Allergan, Inc. |
Sustained drug delivery implant
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
ME03518B
(de)
|
2014-01-21 |
2020-04-20 |
Janssen Pharmaceutica Nv |
Kombinationen mit positiven allosterischen modulatoren von metabotropem glutamatergen rezeptor vom subtyp 2 und deren verwendung
|
KR102502485B1
(ko)
|
2014-01-21 |
2023-02-21 |
얀센 파마슈티카 엔.브이. |
대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
|
EP3223793B1
(de)
|
2014-11-25 |
2023-06-28 |
Eximore Ltd. |
Zusammensetzungen und verfahren zur abgabe eines bioaktiven wirkstoffs oder bioaktiver wirkstoffe
|
US11234897B2
(en)
|
2017-03-27 |
2022-02-01 |
DXM Pharmaceutical, Inc. |
Packaged multi-dose liquid dextromethorphan hydrobromide formulation
|